After 12 months, the ACCURATE study confirmed the benefits of DRG stimulation over traditional SCS for patients with complex regional pain syndrome or peripheral causalgia ST. PAUL, Minn. & LAS VEGAS- ...
Abbott Laboratories (NYSE:ABT)‘s dorsal root ganglion (DRG) stimulation therapy has advantages over traditional spinal cord stimulation (SCS) in the treatment of patients suffering from complex ...
ST. PAUL, Minn. & MONTREAL--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced data from the ACCURATE Study shows that stimulation of the dorsal root ...
Medical device manufacturer, St. Jude Medical, Inc. STJ, recently announced positive data from the ACCURATE study which validated the superiority of the company’s Axium Neurostimulator System over ...
Needle-Delivered Tripolar Electrode Connects to Standard IPG Connectors; Selectively Stimulates Lumbar DRG, Peripheral Nerve, and Sacral Targets from Single Implantable Pulse Generator CLEVELAND, ...
Patients will be able to share information collected in the app with health care providers to provide a comprehensive assessment of the SCS or DRG therapy. A digital health app designed to track and ...
Sometimes the pain following an injury or surgical procedure simply won’t go away. You may try everything your doctor recommends and the discomfort only seems to get worse. This may be caused by ...
Abbott has announced the launch of the new DRG Invisible Trial System, which is approved by the US Food and Drug Administration (FDA) and received CE Mark in Europe. People battling complex chronic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results